Annual figures and changes to the Board of Directors
Net loss for the Group of €12.7m in 2019, an improvement of €0.9m compared to 2018 Cash position of €16.6 million at 31 December 2019 Ms. Corinne Granger joins the…
Read More 
Global Bioenergies reduces its loss
Evry (France), 17 October 2019 – Publication of half-year financial statements as at 30 June 2019, audited and adopted by the Board of Directors at today’s meeting. The report for…
Read More €3.1 million from ADEME to move forward on the IBN-One plant project
Evry (France), 2 October 2019 Global Bioenergies will soon be receiving €2.6 million and IBN-One €0.5 million in the form of repayable advances, following last July’s achievement of a technical…
Read More Changes to the Board of Directors
Evry (France), 05 September 2019 Further to today’s Annual General Meeting, Global Bioenergies announced that BOLD Business Opportunities for L’Oréal Development, now the largest shareholder following the financing transaction of last…
Read More Half-year report on the liquidity contract as of 28/06/2019
Evry (France) – 26 July 2019 – Global Bioenergies (Alternext Paris: ALGBE) presents the half-year report on the liquidity contract entrusted to the brokerage firm Gilbert Dupont. The following assets…
Read More A Shareholders’ Meeting will be held on 5 September 2019
Evry (France), 25 July 2019 – Global Bioenergies has announced that it will hold a shareholder’s meeting on 5 September 2019 at 3pm at its offices located at 5, rue…
Read More Success of the €17m capital increase
Evry (France), on 26 June 2019 Global Bioenergies (the “Company“) announces today having successfully closed its capital increase, launched on 20 June 2019 and conducted through a public offer without…
Read More Launch of a capital increase through a public offer without preferential subscription rights for an initial amount of €17 million supported by the L’Oréal Group and the CM-CIC funds
Participate Capital increase without preferential subscription rights and without priority subscription period through a public offer of an initial amount of €17 million, that may be increased up to €5…
Read More 
